Rachael Carlisle Roehrig, PhD
Rachael Roehrig, PhD, uses her extensive scientific and regulatory experience, as well as technical writing skills, to prepare clients for successful regulatory interactions and FDA advisory committee meetings. Rachael has a special expertise in over-the-counter (OTC) switch projects, having held several executive roles at the Consumer Healthcare Products Association (CHPA), the trade group representing OTC medicine manufacturers. Rachael was previously the director of technical & scientific affairs at CHPA as well as its liaison to the FDA. She is currently Chair of the Steering Committee and member of the Board for the Product Quality Research Institute. Rachael received her doctorate in chemistry from The Johns Hopkins University where she studied photophysical inorganic chemistry applied to molecular cardiobiology.